Segment Information - Schedule of reconciliation to the consolidated net income (loss) (Parenthetical) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
May 31, 2026 |
May 31, 2025 |
|
| Segment Information | ||
| Share based compensation recognized in general and administrative expense | $ 0.6 | $ 0.8 |
| Share based compensation recognized in research and development expense | $ 1.0 | 0.8 |
| Return Of Clinical Expenses | $ 25.0 | |
| X | ||||||||||
- Definition Amount of share based compensation recognized in general and administrative expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of share based compensation recognized in research and development expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of clinical expenses returned to the company. No definition available.
|
| X | ||||||||||
- References No definition available.
|